Skip to main content

Guardant Health Inc (GH) Stock

Guardant Health Inc Stock Details, Movements and Public Alerts

Stock Details

Guardant Health Inc (GH), a prominent company in the healthcare sector within the diagnostics & research industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $87.18. Over the past 52 weeks, it has ranged between $36.36 and $120.74. This places the current price at 72.2% of its 52-week high and 139.8% above its 52-week low. Recent trading volume was recorded at 1,385,355. The 14-day Relative Strength Index (RSI) stands at 29.95, suggesting oversold conditions. The stock is currently trading below its 50-day moving average of $103.65 by 15.89%. Similarly, it is above its 200-day moving average of $76.92 by 13.34%. The MACD histogram is -0.80, indicating bearish momentum (MACD Line: -4.98, Signal Line: -4.18). There is currently 1 active alert set for GH by users.

52-Week Range

$120.74 - $36.36

-27.80% from high · +139.77% from low

Avg Daily Volume

1,979,223

20-day average

100-day avg: 2,338,226

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

55.67

EV/EBITDA

-5.40

EPS (TTM)

-$3.32

Price to Sales

11.42

Beta

1.69

More volatile than market

Q:How is GH valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is GH's risk profile compared to the market?
With a beta of 1.69, Guardant Health Inc is significantly more volatile than the market. For every 10% market move, this stock tends to move 17% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 55.67 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-42.40%

Operating Margin

-42.90%

EBITDA

$-396,561,984

Return on Equity

-4584.00%

Return on Assets

-15.60%

Revenue Growth (YoY)

39.40%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is GH's business model?
Guardant Health Inc achieves a profit margin of -42.40%, meaning it retains $-42.40 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -42.90% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -4584.00% and ROA at -15.60%, the company achieves moderate returns on invested capital.
Q:What are GH's recent growth trends?
Guardant Health Inc's revenue grew by 39.40% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends.0 These growth metrics should be evaluated against DIAGNOSTICS & RESEARCH industry averages for proper context.

Company Size & Market

Market Cap

$11.2B

Revenue (TTM)

$982.02M

Revenue/Share (TTM)

$7.83

Shares Outstanding

131.17M

Book Value/Share

-$0.76

Asset Type

Common Stock

Q:What is GH's market capitalization and position?
Guardant Health Inc has a market capitalization of $11.2B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 131.17M shares outstanding, the company's ownership is relatively concentrated. As a participant in the DIAGNOSTICS & RESEARCH industry, it competes with other firms in this sector.
Q:How does GH's price compare to its book value?
Guardant Health Inc's book value per share is -$0.76, while the current stock price is $87.18, resulting in a price-to-book (P/B) ratio of -114.71. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$132.57

52.06% upside potential

Analyst Recommendations

Strong Buy

5

Buy

17

Hold

2

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for GH?
24 analysts cover GH with 92% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $132.57 implies 52.1% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on GH?
Current analyst recommendations:5 Strong Buy, 17 Buy, 2 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Mar 16, 2026, 02:11 AM

Technical Indicators

RSI (14-day)

29.95

Oversold

50-Day Moving Average

$103.65

-15.89% below MA-50

200-Day Moving Average

$76.92

13.34% above MA-200

MACD Line

-4.98

MACD Signal

-4.18

MACD Histogram

-0.80

Bearish

Q:What does GH's RSI value tell investors?
The RSI (Relative Strength Index) for GH is currently 29.95, indicating the stock is in oversold territory (below 30). This indicates heavy selling pressure that may have pushed the price too low too fast. Oversold readings can present buying opportunities, but stocks can remain oversold in strong downtrends. Look for RSI to rise above 30 as a potential recovery signal. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret GH's MACD and moving average crossovers?
MACD analysis shows the MACD line at -4.98 below the signal line at -4.18, with histogram at -0.80. This bearish crossover indicates downward pressure. The 50-day MA ($103.65) is above the 200-day MA ($76.92), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently between the MAs, suggesting transition.

Indicators last updated: Mar 16, 2026, 01:28 PM

Active Alerts

Alert Condition
Earnings Announcement
Threshold
3 days
Created
Jan 20, 2026, 04:51 PM

Stay Ahead of the Market with Guardant Health Inc Alerts

Set up price alerts for Guardant Health Inc and get notified instantly when the price hits your target. Never miss an important price movement again.